Adverse events. There were no differences between trial treatment limbs in the incidence of adverse events beyond the original trial
| DO (n=60) | Pulse (n=67) | |
|---|---|---|
| Malignancy | 6 | 8 |
| Severe infection requiring admission to hospital | 15 | 19 |
| Cardiovascular disease | 3 | 6 |
| Cerebrovascular disease | 0 | 2 |
| Venous thrombotic event | 6 | 6 |
| New onset diabetes mellitus | 5 | 8 |
| Fracture | 3 | 6 |
DO, daily oral.